Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
| CYT387 inhibits RANKL-induced NFATc1 activation. (A)... | Download ...
CYT387 synergizes with trametinib in pancreatic cells in vitro and in ...
IKBKE/TBK1 inhibitor CYT387 reduced cell viability, cell motility, and ...
| CYT387 impairs the bone resorption function of mature osteoclasts in ...
CYT387 induces apoptosis in HMCL. (a) Representative Annexin-V and PI ...
CYT387 arrests glioblastoma cell cycle on G2/M phase. A, B CYT387 ...
Expression of CSC markers in control, paclitaxel, CYT387 and paclitaxel ...
CYT387 inhibits IKBKE signaling and tumor progression in vivo. ( A ...
CYT387 induces apoptosis in primary samples as a single agent or in ...
CYT387 sulfate salt - EIE CHEMICALS
Tumor burden in mice injected with control, paclitaxel, CYT387 and ...
CYT387 synergises with melphalan and bortezomib in HMCL. (a) Dose ...
CYT387 accelerates glioblastoma cells apoptosis. A, B CYT387 ...
CYT387 inhibited JAK/STAT signaling to alleviate epidermal barrier ...
CYT387 activates the Hippo pathway via inhibiting IKBKE expression. A ...
JAK inhibitors AZD1480 and CYT387 increase apoptosis in canine diffuse ...
CYT387 inhibits JAK and TBK1/IKKε signaling. A, in vitro kinase assay ...
| CYT387 suppresses RANKL-induced osteoclastogenesis in vitro. (A) The ...
JAK1/2 Inhibitors AZD1480 and CYT387 Inhibit Canine B‐Cell Lymphoma ...
Tumor burden in mice injected with control or cisplatin or CYT387 or a ...
Cyt387 | CAS 1056634-68-4 | SCBT - Santa Cruz Biotechnology
CYT387 inhibits IKBKE signaling and tumor progression in vivo. (A ...
CYT387 | CAS 1056634-68-4 | Cayman Chemical | Biomol.com
CYT387 | CAS:1056634-68-4 | JAK-1/-2 inhibitor,ATP competitive | High ...
CYT387 treatment enhanced viral replication in bat intestinal organoids ...
美国APExBIO中文官网 - CYT387 sulfate salt|JAK1/JAK2 inhibitor|CAS# 1056636-06-6
Inhibition of this network by CYT387 suppresses protumorigenic ...
Figure 3 from JAK1/2 Inhibitors AZD1480 and CYT387 Inhibit Canine B ...
Dasatinib and CYT387 combine to inhibit YAP dependent transcription. A ...
CYT387 sulfate salt - ShellChem
| CYT387 ameliorates osteoclast activity in a mouse model of ...
Effect of CYT387 on the proliferation of OVCA 433 cells. OVCA 433 cells ...
| CYT387 reduces RANKL-induced ROS production during... | Download ...
Effect of CYT387 on JAK2 V617F ؉ allelic burden in MPN in vivo. Balb/c ...
Histopathology after CYT387 treatment of JAK2-dependent malignancy in ...
CYT387 CAS: 1056634-68-4品牌：Codow可道广州-盖德化工网
AZD1480 and CYT387 inhibit CLBL-1 cell proliferation. (A)... | Download ...
美国APExBIO中文官网 - CYT387|JAK-1/-2 inhibitor,ATP competitive|CAS# 1056634-68-4
JAK1和JAK2抑制剂(CYT387)
CYT387, a JAK-Specific Inhibitor Impedes Osteoclast Activity and ...
CYT387, a novel JAK2 inhibitor, induces hematologic responses and ...
Frontiers | CYT387, a JAK-Specific Inhibitor Impedes Osteoclast ...
CYT387, a potent IKBKE inhibitor, suppresses human glioblastoma ...
Momelotinib (CYT387) | 莫莫替尼，莫洛替尼 | 购买JAK 抑制剂 - Selleck
Sensitivity of IKBKE-expressing TNBC cells to CYT387. ( A ) Immunoblot ...
Momelotinib (CYT387) Datasheet
APExBIO - CYT387|JAK-1/-2 inhibitor,ATP competitive|CAS# 1056634-68-4
(PDF) CYT387, a JAK-Specific Inhibitor Impedes Osteoclast Activity and ...
YM BioSciences Corporate Presentation | PPT
Momelotinib-d4 dihydrochloride hydrate (CYT387-d4 hydrochloride hydrate ...
Sensitivity of IKBKE-expressing TNBC cells to CYT387. (A) Immunoblot of ...
阿拉丁 化合物 CYT387,JAK 1/2抑制剂 实验室 化学化合物 C127224-5mg【图片 价格 品牌 报价】-京东
Momelotinib-2,2,6,6-d6 (CYT387-2,2,6,6-d6) | Stable Isotope ...
Expression of CSCs and CA125 in mouse tumors generated from ip ...
Activity of CYT387/GSK1120212 combination therapy in an aggressive TNBC ...
Momelotinib (CYT387) | CAS:1056634-68-4 | Manufacturer ChemFaces
Flow cytometry assessment of CSC markers expressed on OVCA 433 cells in ...
Inhibition of JAK and IKBKE signaling by CYT387. (A) Immunoblot of ...
HEY xenograft volume in mice administered with or without paclitaxel ...
Inhibition of KRAS-driven tumorigenicity by interruption of an ...
Immunofluorescence evaluation of P-STAT3 in OVCA 433 cell line treated ...
JCI - Targeting an IKBKE cytokine network impairs triple-negative ...
(PDF) Safety and efficacy of CYT387, a JAK1 and JAK2 inhibitor, in ...
Targeting an IKBKE cytokine network impairs triple-negative breast ...
